Article Information
History
- March 21, 2023.
Article Versions
- Version 1 (March 12, 2023 - 17:06).
- You are currently viewing Version 2 of this article (March 21, 2023 - 08:43).
- Version 3 (April 8, 2023 - 04:50).
- Version 4 (October 31, 2023 - 14:22).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Younes Boulaguiem1,
- Julie Quartier2,3,
- Maria Lapteva2,3,
- Yogeshvar N. Kalia2,3,
- Maria-Pia Victoria-Feser1,
- Stéphane Guerrier1,2,3 and
- Dominique-Laurent Couturier4,5,*
- 1Geneva School of Economics and Management, University of Geneva, Switzerland
- 2School of Pharmaceutical Sciences, University of Geneva, Switzerland
- 3Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland
- 4Medical Research Council Biostatistics Unit, University of Cambridge, England
- 5Cancer Research UK – Cambridge Institute, University of Cambridge, England
- ↵*Corresponding author: dominique.couturier{at}mrc-bsu.cam.ac.uk